Mersana Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.

About MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592.

CEO

Martin H. Huber

CEOMartin H. Huber

Employees

102

Employees102

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2001

Founded2001

Employees

102

Employees102

MRSN Key Statistics

Market cap

43.34M

Market cap43.34M

Price-Earnings ratio

-0.44

Price-Earnings ratio-0.44

Dividend yield

—

Dividend yield—

Average volume

165.00K

Average volume165.00K

High today

$6.80

High today$6.80

Low today

$6.37

Low today$6.37

Open price

$6.66

Open price$6.66

Volume

109.99K

Volume109.99K

52 Week high

$70.75

52 Week high$70.75

52 Week low

$6.37

52 Week low$6.37

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own MRSN. This list is generated using Robinhood data, and it’s not a recommendation.